Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma.

For cirrhotic patients with resectable intermediate-stage HCC, LR may provide survival benefit over TACE, but large-scale studies are required to further stratify patients at this stage for different optimal treatments.